Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Lifetime Risk of Lower-Extremity Peripheral Artery Disease Defined by Ankle-Brachial Index in the United States.

Matsushita K, Sang Y, Ning H, Ballew SH, Chow EK, Grams ME, Selvin E, Allison M, Criqui M, Coresh J, Lloyd-Jones DM, Wilkins JT.

J Am Heart Assoc. 2019 Sep 17;8(18):e012177. doi: 10.1161/JAHA.119.012177. Epub 2019 Sep 10.

2.

Trajectories of Non-HDL Cholesterol Across Midlife: Implications for Cardiovascular Prevention.

Pencina KM, Thanassoulis G, Wilkins JT, Vasan RS, Navar AM, Peterson ED, Pencina MJ, Sniderman AD.

J Am Coll Cardiol. 2019 Jul 9;74(1):70-79. doi: 10.1016/j.jacc.2019.04.047.

PMID:
31272554
3.

Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016.

Perak AM, Ning H, Kit BK, de Ferranti SD, Van Horn LV, Wilkins JT, Lloyd-Jones DM.

JAMA. 2019 May 21;321(19):1895-1905. doi: 10.1001/jama.2019.4984.

PMID:
31112258
4.

10-Year Risk Equations for Incident Heart Failure in the General Population.

Khan SS, Ning H, Shah SJ, Yancy CW, Carnethon M, Berry JD, Mentz RJ, O'Brien E, Correa A, Suthahar N, de Boer RA, Wilkins JT, Lloyd-Jones DM.

J Am Coll Cardiol. 2019 May 21;73(19):2388-2397. doi: 10.1016/j.jacc.2019.02.057.

PMID:
31097157
5.

Lifetime Risks for Hypertension by Contemporary Guidelines in African American and White Men and Women.

Chen V, Ning H, Allen N, Kershaw K, Khan S, Lloyd-Jones DM, Wilkins JT.

JAMA Cardiol. 2019 May 1;4(5):455-459. doi: 10.1001/jamacardio.2019.0529.

PMID:
30916719
6.

Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality.

Zhong VW, Van Horn L, Cornelis MC, Wilkins JT, Ning H, Carnethon MR, Greenland P, Mentz RJ, Tucker KL, Zhao L, Norwood AF, Lloyd-Jones DM, Allen NB.

JAMA. 2019 Mar 19;321(11):1081-1095. doi: 10.1001/jama.2019.1572.

7.

Dietary patterns during adulthood and cognitive performance in midlife: The CARDIA study.

McEvoy CT, Hoang T, Sidney S, Steffen LM, Jacobs DR Jr, Shikany JM, Wilkins JT, Yaffe K.

Neurology. 2019 Apr 2;92(14):e1589-e1599. doi: 10.1212/WNL.0000000000007243. Epub 2019 Mar 6.

PMID:
30842290
8.

Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659. No abstract available.

PMID:
30700139
9.

Long-term Absolute Risk for Cardiovascular Disease Stratified by Fasting Glucose Level.

Bancks MP, Ning H, Allen NB, Bertoni AG, Carnethon MR, Correa A, Echouffo-Tcheugui JB, Lange LA, Lloyd-Jones DM, Wilkins JT.

Diabetes Care. 2019 Mar;42(3):457-465. doi: 10.2337/dc18-1773. Epub 2019 Jan 7.

PMID:
30617142
10.

HDL modification: recent developments and their relevance to atherosclerotic cardiovascular disease.

Wilkins JT, Seckler HS.

Curr Opin Lipidol. 2019 Feb;30(1):24-29. doi: 10.1097/MOL.0000000000000571.

PMID:
30531230
11.

Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated.

Sniderman AD, Thanassoulis G, Wilkins JT, Furberg CD, Pencina M.

J Am Heart Assoc. 2018 Oct 2;7(19):e010049. doi: 10.1161/JAHA.118.010049. No abstract available.

12.

USPSTF Recommendations for Assessment of Cardiovascular Risk With Nontraditional Risk Factors: Finding the Right Tests for the Right Patients.

Wilkins JT, Lloyd-Jones DM.

JAMA. 2018 Jul 17;320(3):242-244. doi: 10.1001/jama.2018.9346. No abstract available.

PMID:
29998347
13.

APOL1 Sends Its REGARDS to Cardiovascular Disease.

Waitzman JS, Wilkins JT, Lin J.

Circ Genom Precis Med. 2018 Jun;11(6):e002212. doi: 10.1161/CIRCGEN.118.002212. No abstract available. Erratum in: Circ Genom Precis Med. 2018 Sep;11(9):e000049.

14.

Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confounding.

Sniderman AD, Couture P, Martin SS, DeGraaf J, Lawler PR, Cromwell WC, Wilkins JT, Thanassoulis G.

J Lipid Res. 2018 Jul;59(7):1266-1275. doi: 10.1194/jlr.R082271. Epub 2018 May 16. Review.

15.

A Targeted, Differential Top-Down Proteomic Methodology for Comparison of ApoA-I Proteoforms in Individuals with High and Low HDL Efflux Capacity.

Seckler HDS, Fornelli L, Mutharasan RK, Thaxton CS, Fellers R, Daviglus M, Sniderman A, Rader D, Kelleher NL, Lloyd-Jones DM, Compton PD, Wilkins JT.

J Proteome Res. 2018 Jun 1;17(6):2156-2164. doi: 10.1021/acs.jproteome.8b00100. Epub 2018 Apr 27.

16.

Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity.

Khan SS, Ning H, Wilkins JT, Allen N, Carnethon M, Berry JD, Sweis RN, Lloyd-Jones DM.

JAMA Cardiol. 2018 Apr 1;3(4):280-287. doi: 10.1001/jamacardio.2018.0022.

17.

Cochrane corner: PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.

Schmidt AF, Pearce LS, Wilkins JT, Casas JP, Hingorani AD.

Heart. 2018 Jul;104(13):1053-1055. doi: 10.1136/heartjnl-2017-312858. Epub 2018 Feb 14. No abstract available.

PMID:
29444808
18.

Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.

Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, de Ferranti SD, Ferguson JF, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Lutsey PL, Mackey JS, Matchar DB, Matsushita K, Mussolino ME, Nasir K, O'Flaherty M, Palaniappan LP, Pandey A, Pandey DK, Reeves MJ, Ritchey MD, Rodriguez CJ, Roth GA, Rosamond WD, Sampson UKA, Satou GM, Shah SH, Spartano NL, Tirschwell DL, Tsao CW, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31. Review. No abstract available. Erratum in: Circulation. 2018 Mar 20;137(12 ):e493.

PMID:
29386200
19.

Discordance between lipoprotein particle number and cholesterol content: an update.

Cantey EP, Wilkins JT.

Curr Opin Endocrinol Diabetes Obes. 2018 Apr;25(2):130-136. doi: 10.1097/MED.0000000000000389. Review.

PMID:
29324459
20.

Tobacco Smoking Is a Medical Problem. We Ought to Treat It Like One.

Kalhan R, Wilkins JT, Hitsman BL.

Am J Respir Crit Care Med. 2018 Apr 1;197(7):852-853. doi: 10.1164/rccm.201711-2354ED. No abstract available.

21.

Reply.

VanWagner LB, Ning H, Whitsett M, Levitsky J, Uttal S, Wilkins JT, Abecassis MM, Ladner DP, Skaro AI, Lloyd-Jones DM.

Hepatology. 2017 Dec;66(6):2089-2090. doi: 10.1002/hep.29525. Epub 2017 Nov 6. No abstract available.

PMID:
28921593
22.

A point-based prediction model for cardiovascular risk in orthotopic liver transplantation: The CAR-OLT score.

VanWagner LB, Ning H, Whitsett M, Levitsky J, Uttal S, Wilkins JT, Abecassis MM, Ladner DP, Skaro AI, Lloyd-Jones DM.

Hepatology. 2017 Dec;66(6):1968-1979. doi: 10.1002/hep.29329. Epub 2017 Nov 6.

23.

Pulmonary hospitalizations and ischemic heart disease events in patients with peripheral artery disease.

McDermott MM, Tian L, Wunderink RG, Kalhan R, Kibbe MR, Greenland P, Tracy R, Zhao L, Liu K, Huffman M, Wilkins JT, Liao Y, Shah S, Lloyd Jones D, Green D.

Vasc Med. 2017 Jun;22(3):218-224. doi: 10.1177/1358863X16680461. Epub 2016 Dec 15.

24.

PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease.

Schmidt AF, Pearce LS, Wilkins JT, Overington JP, Hingorani AD, Casas JP.

Cochrane Database Syst Rev. 2017 Apr 28;4:CD011748. doi: 10.1002/14651858.CD011748.pub2. Review.

25.

Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jiménez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P; American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25. Review. No abstract available. Erratum in: Circulation. 2017 Mar 7;135(10 ):e646. Circulation. 2017 Sep 5;136(10 ):e196.

26.

HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study.

Mutharasan RK, Thaxton CS, Berry J, Daviglus ML, Yuan C, Sun J, Ayers C, Lloyd-Jones DM, Wilkins JT.

J Lipid Res. 2017 Mar;58(3):600-606. doi: 10.1194/jlr.P069039. Epub 2017 Jan 3.

27.

Hypertension, Obesity, Diabetes, and Heart Failure-Free Survival: The Cardiovascular Disease Lifetime Risk Pooling Project.

Ahmad FS, Ning H, Rich JD, Yancy CW, Lloyd-Jones DM, Wilkins JT.

JACC Heart Fail. 2016 Dec;4(12):911-919. doi: 10.1016/j.jchf.2016.08.001. Epub 2016 Oct 12.

28.

High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study.

Ko DT, Alter DA, Guo H, Koh M, Lau G, Austin PC, Booth GL, Hogg W, Jackevicius CA, Lee DS, Wijeysundera HC, Wilkins JT, Tu JV.

J Am Coll Cardiol. 2016 Nov 8;68(19):2073-2083. doi: 10.1016/j.jacc.2016.08.038.

29.

Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.

Perak AM, Ning H, de Ferranti SD, Gooding HC, Wilkins JT, Lloyd-Jones DM.

Circulation. 2016 Jul 5;134(1):9-19. doi: 10.1161/CIRCULATIONAHA.116.022335.

30.

Reply: Clinical Significance and Potential Mechanism of Discordance Between Apolipoprotein B and LDL-Cholesterol.

Wilkins JT, Sniderman A, Lloyd-Jones DM.

J Am Coll Cardiol. 2016 Jun 28;67(25):3024-5. doi: 10.1016/j.jacc.2016.03.579. No abstract available.

31.

Association of the von Willebrand Factor-ADAMTS13 Ratio With Incident Cardiovascular Events in Patients With Peripheral Arterial Disease.

Green D, Tian L, Greenland P, Liu K, Kibbe M, Tracy R, Shah S, Wilkins JT, Huffman MD, Liao Y, Lloyd Jones D, McDermott MM.

Clin Appl Thromb Hemost. 2017 Oct;23(7):807-813. doi: 10.1177/1076029616655615. Epub 2016 Jun 17.

32.

Prevention: HOPE-3 trial - targeting BP and LDL-C in at-risk patients.

Wilkins JT, Lloyd-Jones DM.

Nat Rev Cardiol. 2016 May 16;13(6):315-6. doi: 10.1038/nrcardio.2016.74. No abstract available.

PMID:
27181913
33.

Community walking speed, sedentary or lying down time, and mortality in peripheral artery disease.

McDermott MM, Guralnik JM, Ferrucci L, Tian L, Kibbe MR, Greenland P, Green D, Liu K, Zhao L, Wilkins JT, Huffman MD, Shah SJ, Liao Y, Gao Y, Lloyd-Jones DM, Criqui MH.

Vasc Med. 2016 Apr;21(2):120-9. doi: 10.1177/1358863X15626521. Epub 2016 Feb 12.

34.

Discordance Between Apolipoprotein B and LDL-Cholesterol in Young Adults Predicts Coronary Artery Calcification: The CARDIA Study.

Wilkins JT, Li RC, Sniderman A, Chan C, Lloyd-Jones DM.

J Am Coll Cardiol. 2016 Jan 19;67(2):193-201. doi: 10.1016/j.jacc.2015.10.055.

35.

Reducing protein oxidation in low-flow electrospray enables deeper investigation of proteoforms by top down proteomics.

Kim K, Compton PD, Toby TK, Thomas PM, Wilkins JT, Mutharasan RK, Kelleher NL.

EuPA Open Proteom. 2015 Sep;8:40-47. Epub 2015 Jun 5.

36.

Changes in D-dimer and inflammatory biomarkers before ischemic events in patients with peripheral artery disease: The BRAVO Study.

McDermott MM, Liu K, Green D, Greenland P, Tian L, Kibbe M, Tracy R, Shah S, Wilkins JT, Huffman M, Zhao L, Huang CC, Auerbach A, Liao Y, Skelly CL, McCarthy W, Lloyd Jones D.

Vasc Med. 2016 Feb;21(1):12-20. doi: 10.1177/1358863X15617541. Epub 2015 Dec 7.

37.

HDL cholesterol and stroke risk: The Multi-Ethnic Study of Atherosclerosis.

Reina SA, Llabre MM, Allison MA, Wilkins JT, Mendez AJ, Arnan MK, Schneiderman N, Sacco RL, Carnethon M, Delaney JA.

Atherosclerosis. 2015 Nov;243(1):314-9. doi: 10.1016/j.atherosclerosis.2015.09.031. Epub 2015 Sep 28.

38.

Data Resource Profile: The Cardiovascular Disease Lifetime Risk Pooling Project.

Wilkins JT, Karmali KN, Huffman MD, Allen NB, Ning H, Berry JD, Garside DB, Dyer A, Lloyd-Jones DM.

Int J Epidemiol. 2015 Oct;44(5):1557-64. doi: 10.1093/ije/dyv150. Epub 2015 Aug 14. No abstract available.

39.

Association of 6-Minute Walk Performance and Physical Activity With Incident Ischemic Heart Disease Events and Stroke in Peripheral Artery Disease.

McDermott MM, Greenland P, Tian L, Kibbe MR, Green D, Zhao L, Criqui MH, Guralnik JM, Ferrucci L, Liu K, Wilkins JT, Huffman MD, Shah SJ, Liao Y, Lloyd-Jones DM.

J Am Heart Assoc. 2015 Jul 28;4(7). pii: e001846. doi: 10.1161/JAHA.115.001846.

40.

High early cardiovascular mortality after liver transplantation.

VanWagner LB, Lapin B, Levitsky J, Wilkins JT, Abecassis MM, Skaro AI, Lloyd-Jones DM.

Liver Transpl. 2014 Nov;20(11):1306-16. doi: 10.1002/lt.23950. Epub 2014 Oct 24.

41.

Coronary heart disease risks associated with high levels of HDL cholesterol.

Wilkins JT, Ning H, Stone NJ, Criqui MH, Zhao L, Greenland P, Lloyd-Jones DM.

J Am Heart Assoc. 2014 Mar 13;3(2):e000519. doi: 10.1161/JAHA.113.000519.

42.

Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age.

Allen NB, Siddique J, Wilkins JT, Shay C, Lewis CE, Goff DC, Jacobs DR Jr, Liu K, Lloyd-Jones D.

JAMA. 2014 Feb 5;311(5):490-7. doi: 10.1001/jama.2013.285122. Erratum in: JAMA. 2014 Apr 16;311(15):1568.

43.

Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial.

Ross MI, Wu E, Wilkins JT, Gupta D, Shen S, Aulwes D, Montero K, Holly TA.

J Nucl Cardiol. 2013 Apr;20(2):197-204. doi: 10.1007/s12350-013-9679-1. Epub 2013 Feb 13.

PMID:
23404232
44.

Lifetime risk and years lived free of total cardiovascular disease.

Wilkins JT, Ning H, Berry J, Zhao L, Dyer AR, Lloyd-Jones DM.

JAMA. 2012 Nov 7;308(17):1795-801. doi: 10.1001/jama.2012.14312.

45.

High density GWAS for LDL cholesterol in African Americans using electronic medical records reveals a strong protective variant in APOE.

Rasmussen-Torvik LJ, Pacheco JA, Wilke RA, Thompson WK, Ritchie MD, Kho AN, Muthalagu A, Hayes MG, Armstrong LL, Scheftner DA, Wilkins JT, Zuvich RL, Crosslin D, Roden DM, Denny JC, Jarvik GP, Carlson CS, Kullo IJ, Bielinski SJ, McCarty CA, Li R, Manolio TA, Crawford DC, Chisholm RL.

Clin Transl Sci. 2012 Oct;5(5):394-9. doi: 10.1111/j.1752-8062.2012.00446.x. Epub 2012 Aug 23.

46.

Associations between a parental history of premature cardiovascular disease and coronary artery calcium and carotid intima-media thickness: the Coronary Artery Risk Development In Young Adults (CARDIA) study.

Wilkins JT, Gidding S, Liu K, Ning H, Polak JF, Lloyd-Jones DM.

Eur J Prev Cardiol. 2014 May;21(5):601-7. doi: 10.1177/2047487312462801. Epub 2012 Oct 1.

47.

Are novel serum biomarkers informative?

Wilkins JT, Lloyd-Jones DM.

Med Clin North Am. 2012 Jan;96(1):1-11. doi: 10.1016/j.mcna.2012.01.017. Review.

PMID:
22391247
48.

Associations of noninvasive measures of arterial compliance and ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA).

Wilkins JT, McDermott MM, Liu K, Chan C, Criqui MH, Lloyd-Jones DM.

Am J Hypertens. 2012 May;25(5):535-41. doi: 10.1038/ajh.2012.13. Epub 2012 Feb 23.

49.

Biomarkers for coronary heart disease clinical risk prediction: a critical appraisal. Counterpoint.

Wilkins JT, Lloyd-Jones DM.

Prev Cardiol. 2010 Fall;13(4):160-5. doi: 10.1111/j.1751-7141.2010.00081.x. Review.

50.

Contractile properties of adjacent segments of single human muscle fibers.

Wilkins JT, Krivickas LS, Goldstein R, Suh D, Frontera WR.

Muscle Nerve. 2001 Oct;24(10):1319-26.

PMID:
11562911

Supplemental Content

Loading ...
Support Center